Drug Shortage Report for MYLAN-TOLTERODINE ER

Last updated on 2022-02-15 History
Report ID 17787
Drug Identification Number 02404184
Brand name MYLAN-TOLTERODINE ER
Common or Proper name TOLTERODINE ER
Company Name MYLAN PHARMACEUTICALS ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) TOLTERODINE TARTRATE
Strength(s) 2MG
Dosage form(s) CAPSULE (EXTENDED RELEASE)
Route of administration ORAL
Packaging size 100BT, 30BT
ATC code G04BD
ATC description OTHER UROLOGICALS, INCL ANTISPASMODICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2017-10-10
Actual start date 2017-10-10
Estimated end date Unknown
Actual end date 2022-02-14
Shortage status Resolved
Updated date 2022-02-15
Company comments Last lot 3079138, Expiry August-31-2018
Health Canada comments
Tier 3 Status No
Contact Address 85 ADVANCE ROAD
ETOBICOKE, ONTARIO
CANADA M8Z 2S6
Company contact information Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v20 2017-09-28 English Compare
v19 2017-09-22 French Compare
v18 2017-09-22 English Compare
v17 2017-09-22 English Compare
v16 2017-09-08 French Compare
v15 2017-09-08 English Compare
v14 2017-08-29 French Compare
v13 2017-08-29 English Compare
v12 2017-08-29 English Compare
v11 2017-08-29 French Compare
v10 2017-08-29 English Compare
v9 2017-08-29 English Compare
v8 2017-08-22 French Compare
v7 2017-08-22 English Compare
v6 2017-08-15 French Compare
v5 2017-08-15 English Compare
v4 2017-08-10 French Compare
v3 2017-08-10 English Compare
v2 2017-08-01 French Compare
v1 2017-08-01 English Compare

Showing 41 to 60 of 60